A Clinical Review of Biosimilars Approved in Oncology.
Dat NgoJason ChenPublished in: The Annals of pharmacotherapy (2020)
The major concerns of biosimilars revolve around their long-term efficacy and safety. Even with many questions to be answered, biosimilars have the potential for significant cost savings in the US health care system.
Keyphrases